Salivary gland cancer

The names of the lead clinicians for the IRCI Salivary gland cancer group include:

Dr Dr Robert Metcalf (UK)
Dr Alan Ho (US)
Dr Lisa Licitra (EORTC)

Current active trial

EORTC1206-HNCG – A randomised phase II study to evaluate the efficacy and safety of chemotherapy vs androgen deprivation therapy in patients with recurrent and/or metastatic, androgen receptor expressing, salivary gland cancer – an International Rare Cancers Initiative Study – IRCI 007

› Read more

Informative websites

Cancer Help, Cancer Research UK

National Cancer Institute

Institut National Du Cancer

Rare Cancer Types

Active groups